KEVIN RAKIN
CIK 1184421 · last filed 2026-06-15
KEVIN RAKIN is a corporate insider who has filed 49 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for ELUT, was dated Jun 15, 2026. Across all open-market trades the lifetime net is +$74.6M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.60M
6
49
$74.62M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELUT | Director | 518,539 | $0.92 | $474.5K | $296.8K | 6 | 2026-06-15 |
| QSI | Director | 1,220,512 | $0.76 | $928.3K | -$191.2K | 8 | 2026-05-20 |
| ORMP | Director | 46,661 | $4.17 | $194.6K | -$536.9K | 17 | 2022-03-22 |
| ELUTIA INC. (AZYO) Delisted | Director | 4,062,451 | $1.49 | $6.05M | $75.00M | 1 | 2020-10-13 |
| Omrix Biopharmaceuticals, Inc. (OMRI) Delisted | Director | 6,000 | — | — | $27.3K | 4 | 2008-09-05 |
| VION PHARMACEUTICALS INC (VION) Delisted | Director | 6,100 | — | — | $23.9K | 3 | 2007-06-28 |
Recent Filings
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-15 | ELUT | Grant (A) | — | $0 | EDGAR |
| 2026-05-20 | QSI | Grant (A) | — | $0 | EDGAR |
| 2026-02-02 | ELUT | Buy (P) | +280,000 | $296.8K | EDGAR |
| 2025-12-17 | ELUT | Other (J) | −4,505,941 | $0 | EDGAR |
| 2025-12-15 | ELUT | Other (J) | −4,372,497 | $0 | EDGAR |
| 2025-06-02 | ELUT | Grant (A) | — | $0 | EDGAR |
| 2025-05-21 | QSI | Grant (A) | — | $0 | EDGAR |
| 2024-06-10 | ELUT | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | QSI | Grant (A) | — | $0 | EDGAR |
| 2023-05-16 | QSI | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.